Mondelez International Inc (MDLZ34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 22 Oct 2026
Key indicators
| Last close | BRL 54.70 |
|---|---|
| 52-week range | 46.17 – 56.47 |
| Return, 1 month / 3 months | +4.9% / +6.4% |
| Return, 1 year / 3 years | +4.6% / +21.1% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 34.8% |
| Worst drawdown (1 year) | -15.9% |
| Average daily value traded | 0.03M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mondelez International is a snacks company that makes biscuits, chocolate, candy and gum. Its brands include Oreo cookies, Cadbury chocolate and Trident gum, and its products reach shoppers through grocery stores, convenience shops and other retailers in many countries. The company is based in the United States and runs manufacturing and distribution across several regions, serving households and retail customers with packaged foods and confectionery.
Mondelez International Inc is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code MDLZ34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mondelez International Inc (MDLZ34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 54.70 on 22 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 248 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.6% and over the last three months it rose 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.5% | ||
| From 52-week high | -2.3% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.4% | ||
| 6-month return | 22.0% | ||
| 12-month return, skipping the last month | -0.3% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.9% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M BRL | ||
| Zero-volume days | 6.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | +4.9% |
| 3 months | +6.4% |
| 6 months | +22.0% |
| 1 year | +4.6% |
| 3 years | +21.1% |
| 5 years | +24.9% |
Signals
| 50-day / 200-day average | 53.20 / 50.43 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Jun 2026 | USD 5.1250 |
| 27 Mar 2026 | USD 2.5327 |
| 29 Dec 2025 | USD 2.7314 |
| 26 Sep 2025 | USD 2.7627 |
| 26 Jun 2025 | USD 2.6500 |
| 27 Mar 2025 | USD 2.7993 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.